Eliyahou Et Al Harari bought $411K of CapsoVision (CV)
Executed Jul 17, disclosed Jul 21, 4 days later.
Over the 21 trading sessions from the disclosed entry session (Jul 21), the stock returned -12.6% (delay-adjusted); from the execution session (Jul 17), -3.0%. Derived: entry at the session's open, exit at the close 20 sessions later.
Eliyahou Et Al Harari (10% owner) filed 3 Form 4 reports in the trailing twelve months (3 purchases, 0 sales, 1 filed past the two-business-day deadline), most often in CapsoVision, Inc. (CV). Across 3 priced purchase filings, the average 21-session return was +2.0% from execution and +4.8% from disclosure (delay-adjusted; derived). The largest single filing was $495K of CV (81,300 sh × $6.09, as filed), executed Jul 8.
Healthcare · CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of t…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→81,300 sh × $6.09
Exec Jul 8
Filed Jul 10 · 8:17 PM ET CVPURCHASE CapsoVision, Inc. $102K
13,850 sh × $7.35
Exec Jun 26
Filed Jul 7 · 10:03 PM ET †